Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Thomas J Hwang, M.D.

Concepts (215)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Drug Approval3320248146.590 Why?
United States Food and Drug Administration32202416643.060 Why?
Device Approval920231632.930 Why?
Drug Costs13202311832.820 Why?
Prescription Drugs720236312.350 Why?
Legislation, Drug620232142.240 Why?
Medicare Part D520223552.210 Why?
European Union920241572.110 Why?
Rare Diseases520196221.840 Why?
Drug Information Services32020511.790 Why?
Clinical Trials as Topic15202480021.690 Why?
Drugs, Investigational520192121.610 Why?
Product Surveillance, Postmarketing520234521.560 Why?
Drug Discovery7201710511.380 Why?
Drug and Narcotic Control220221441.280 Why?
Antineoplastic Agents152024136391.270 Why?
Neoplasms182024221701.260 Why?
Government Regulation320195241.180 Why?
Medicare Part B220191171.080 Why?
Orphan Drug Production42018480.990 Why?
Pediatrics6202035890.960 Why?
Consumer Product Safety220161220.940 Why?
Policy Making420165420.930 Why?
United States542024723340.900 Why?
Biomedical Research6201934290.870 Why?
Health Care Reform2202212470.860 Why?
BCG Vaccine220233690.840 Why?
Medicaid4202328180.830 Why?
Drugs, Essential12022720.790 Why?
Pharmaceutical Preparations9202310890.740 Why?
Drug Industry820237880.740 Why?
Federal Government120222670.720 Why?
Europe11202334220.690 Why?
Health Policy7202026840.690 Why?
Prescription Fees220211530.670 Why?
Inflation, Economic12019300.660 Why?
Cost Sharing220224090.660 Why?
Technology Assessment, Biomedical120223070.650 Why?
Drug Evaluation120206410.650 Why?
Commerce220156060.640 Why?
Health Expenditures3202223660.630 Why?
Cultural Diversity120223690.630 Why?
Clinical Trials, Phase III as Topic320188570.620 Why?
Urologic Neoplasms120223140.610 Why?
Artificial Intelligence2202425780.580 Why?
Tuberculosis, Multidrug-Resistant320149340.570 Why?
Medical Device Recalls12016150.550 Why?
Anti-Bacterial Agents4201674070.540 Why?
World Health Organization1202213220.540 Why?
Medicine120249420.520 Why?
Costs and Cost Analysis4202316680.500 Why?
State Health Plans120172190.500 Why?
Health Planning Technical Assistance1201450.490 Why?
Surgical Equipment12015570.490 Why?
Decision Support Systems, Clinical1202411750.490 Why?
Public-Private Sector Partnerships120161220.490 Why?
Insurance, Pharmaceutical Services120173480.480 Why?
Small Business1201490.480 Why?
Program Development2202012970.470 Why?
Visual Prosthesis12015480.460 Why?
Leprostatic Agents12014140.460 Why?
Humans8120247615040.460 Why?
Clofazimine12014410.450 Why?
Equipment and Supplies120162730.440 Why?
Extensively Drug-Resistant Tuberculosis12014850.430 Why?
Urinary Bladder Neoplasms2202322230.430 Why?
Information Seeking Behavior120141160.430 Why?
Publishing220188330.420 Why?
Research Design3201961800.420 Why?
Reimbursement Mechanisms220166670.420 Why?
Oxazolidinones12013980.420 Why?
Cycloserine120131180.410 Why?
Motivation1202220060.410 Why?
Negotiating120141500.410 Why?
Information Dissemination1202011260.400 Why?
Fluoroquinolones120143070.390 Why?
Investments120131470.390 Why?
United States Department of Veterans Affairs120169280.380 Why?
Isoxazoles120132320.380 Why?
Drug Labeling320202480.380 Why?
Drug Resistance, Bacterial2201610480.370 Why?
Cardiovascular Agents120178400.370 Why?
Politics220168150.370 Why?
Treatment Failure1201626450.350 Why?
Escherichia coli Infections120145180.340 Why?
Reimbursement, Incentive120155430.340 Why?
Drug Resistance, Multiple, Bacterial120145870.330 Why?
Contact Tracing120112710.330 Why?
Drug Utilization1201511880.330 Why?
Migraine Disorders1202217010.320 Why?
Retinal Diseases120157050.320 Why?
Ophthalmology120155500.310 Why?
Patient Selection1202042440.300 Why?
National Health Programs120114400.300 Why?
Marketing220222200.300 Why?
Molecular Targeted Therapy4202428110.300 Why?
Prostheses and Implants1201512710.300 Why?
Switzerland320233240.290 Why?
Urinary Tract Infections120148020.290 Why?
Guidelines as Topic1201413860.290 Why?
Vaccines120168440.280 Why?
Child142023801530.280 Why?
Bacterial Infections1201513900.280 Why?
Anti-Infective Agents120149830.270 Why?
Antitubercular Agents1201413750.260 Why?
Outpatients1201415970.260 Why?
Communicable Diseases120148750.260 Why?
Software1201944340.250 Why?
Canada2202221220.240 Why?
Opioid-Related Disorders1201921640.240 Why?
Therapies, Investigational220161110.240 Why?
Hypoglycemic Agents1201730850.230 Why?
Pain1201950730.230 Why?
Drugs, Generic220224480.230 Why?
Health Services Accessibility4201854400.230 Why?
Analgesics, Opioid1201938080.220 Why?
Ambulatory Care1201427750.210 Why?
Coronavirus Infections1202030840.210 Why?
Pneumonia, Viral1202032040.210 Why?
Government Agencies220191600.200 Why?
Escherichia coli1201442170.190 Why?
Cohort Studies62023414870.190 Why?
Patient-Centered Care2202314210.190 Why?
Cardiovascular Diseases22017155000.190 Why?
Quality of Life32020133670.190 Why?
Medical Oncology3202423210.180 Why?
Central Nervous System Diseases220155200.170 Why?
Television120234080.170 Why?
Prescriptions120223860.170 Why?
Tuberculosis1201120170.160 Why?
Biological Factors120191570.150 Why?
Patents as Topic120191110.150 Why?
Medicare2202167700.150 Why?
Databases, Factual4201879670.150 Why?
Japan1202213780.150 Why?
Retrospective Studies72023806360.140 Why?
Tropical Medicine12017510.140 Why?
Early Termination of Clinical Trials12016690.140 Why?
Clinical Trials, Phase I as Topic220173260.140 Why?
Cost-Benefit Analysis3202154920.130 Why?
Practice Guidelines as Topic3202473900.130 Why?
Time Factors52019399670.130 Why?
United States Government Agencies12015260.130 Why?
Neoplasm Invasiveness1202335950.130 Why?
Conjunctivitis, Bacterial12015220.120 Why?
Central Nervous System Agents12015750.120 Why?
New York120178740.120 Why?
Public Policy120195590.120 Why?
Encyclopedias as Topic12014190.120 Why?
Area Under Curve1201816380.120 Why?
Compassionate Use Trials12014500.120 Why?
Capital Financing12014580.110 Why?
Small Molecule Libraries120197330.110 Why?
Lenses, Intraocular120151390.110 Why?
Equipment Safety120142490.110 Why?
Diabetes Mellitus, Type 212017121480.110 Why?
Cross-Sectional Studies52024261250.110 Why?
Antibiotics, Antitubercular12013990.100 Why?
Public Opinion120164840.100 Why?
California1201614290.100 Why?
Infant32020361920.100 Why?
Statistics, Nonparametric2201828500.100 Why?
Age Factors22020183950.100 Why?
Safety1201611500.100 Why?
Child, Preschool32020422300.100 Why?
Randomized Controlled Trials as Topic32019102090.100 Why?
Clinical Trials, Phase II as Topic120146290.100 Why?
Diffusion of Innovation120167280.090 Why?
Adolescent52023883190.090 Why?
Models, Economic120137160.080 Why?
Biological Products120189140.080 Why?
Germany220228750.080 Why?
Regression Analysis1201863430.080 Why?
Disease-Free Survival1201868140.080 Why?
Immunotherapy1202346520.070 Why?
Insurance Coverage1201919400.070 Why?
Needs Assessment1201411390.070 Why?
Macular Degeneration1201510070.070 Why?
Infant, Newborn22019261980.070 Why?
Microbial Sensitivity Tests1201419370.070 Why?
Policy220215080.070 Why?
Periodicals as Topic1201614630.060 Why?
Aged420221692890.060 Why?
Quality Improvement1202038010.060 Why?
Neoplasm Recurrence, Local1202392800.060 Why?
Drug Prescriptions1201416700.060 Why?
Proportional Hazards Models12019124630.060 Why?
Decision Making2201539290.050 Why?
Inpatients1201525480.050 Why?
Treatment Outcome32019646800.050 Why?
Internet1201430920.050 Why?
Pandemics1202086540.040 Why?
Systems Analysis120201690.040 Why?
Developing Countries1201128850.040 Why?
France120204970.040 Why?
England120205260.040 Why?
Neglected Diseases12018660.040 Why?
Administration, Intravesical12017920.040 Why?
Follow-Up Studies12019391060.040 Why?
Computer Graphics120193400.040 Why?
Endpoint Determination120195900.030 Why?
Pharmacology, Clinical12015220.030 Why?
Male520193608040.030 Why?
Female520193926440.030 Why?
Ophthalmic Solutions120153130.030 Why?
Financing, Government120174720.030 Why?
Mental Disorders1201368450.030 Why?
Algorithms12013140310.030 Why?
Genome, Human1202444250.020 Why?
Patient Participation1201914440.020 Why?
Genomics1202458210.020 Why?
Young Adult12014592430.020 Why?
Health Care Costs1201732420.010 Why?
Middle Aged120142208950.010 Why?
Adult120142211770.010 Why?
Hwang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (215)
Explore
_
Co-Authors (24)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.